SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Current Liabilities | - | - | - | - |
What is the latest Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
How is Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | - | |
Compare Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,385.6 Cr | -8.3% | -6% | 47.5% | Stock Analytics | |
| PRIME FOCUS | ₹22,067.9 Cr | 4.4% | 18.3% | 82.8% | Stock Analytics | |
| SAGILITY | ₹19,343.2 Cr | -1.4% | 3.7% | -6.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,853.2 Cr | -0.4% | -5.2% | -33.3% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,766.9 Cr | -0.6% | -4% | -10% | Stock Analytics | |
| INDEGENE | ₹12,267.9 Cr | 0.4% | -1.6% | -9.6% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -8.3% |
-6% |
47.5% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses